Bernd Brauninger

Q: What is Bernd Brauninger email address?

Email Bernd Brauninger at bernd.braeuninger@gmx.de and bernd.brauninger@boehringer-ingelheim.com. This email is the most updated Bernd Brauninger's email found in 2026.

Q: How to contact Bernd Brauninger?

To contact Bernd Brauninger send an email to bernd.braeuninger@gmx.de or bernd.brauninger@boehringer-ingelheim.com. (updated on February 24, 2025)

Head of Digital Development Strategies and Operational Excellence (Nonclinical Drug Development) at Boehringer Ingelheim | Ulm, Baden-Württemberg, Germany

About Bernd Brauninger

Bernd Brauninger currently serves as the Head of Digital Development Strategies and Operational Excellence within Boehringer Ingelheim’s Nonclinical Drug Development division. In this pivotal role, he leverages his extensive expertise in pharma and IT to drive innovative digital transformation initiatives that enhance operational efficiency, data integrity, and regulatory compliance. His strategic focus is on integrating advanced data management systems, automation, and process optimization to streamline nonclinical workflows, ultimately accelerating the path from research to clinical application.

A key aspect of Bernd’s work involves harnessing synergies between business processes, data, and technology to foster a seamless interface across nonclinical development functions. His proficiency in methodologies such as Lean Six Sigma enables him to implement continuous improvement initiatives, reducing variability and increasing process robustness. Additionally, his technical skills in programming languages like Python, C++, and VBA, combined with expertise in computer validation and data integrity standards (A.L.C.O.A+), empower him to develop innovative digital solutions that ensure compliance and data quality.

Bernd’s leadership in operational excellence emphasizes the importance of digital innovation in nonclinical drug development, including the deployment of automation tools, data analytics, and visualization techniques to support decision-making. His passion for translating complex digital strategies into tangible value for patients and healthcare providers underscores his commitment to advancing pharmaceutical research through technology. By fostering cross-functional collaboration and embracing emerging digital trends, Bernd aims to position Boehringer Ingelheim at the forefront of nonclinical development excellence, ultimately contributing to more efficient, compliant, and patient-centric drug development processes.

Bernd Brauninger Work